LEFT INTERNAL MAMMARY ELONGATION WITH INFERIOR EPIGASTRIC ARTERY IN MINIMALLY INVASIVE CORONARY SURGERY

Citation
Am. Calafiore et al., LEFT INTERNAL MAMMARY ELONGATION WITH INFERIOR EPIGASTRIC ARTERY IN MINIMALLY INVASIVE CORONARY SURGERY, European journal of cardio-thoracic surgery, 12(3), 1997, pp. 393-396
Citations number
8
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
10107940
Volume
12
Issue
3
Year of publication
1997
Pages
393 - 396
Database
ISI
SICI code
1010-7940(1997)12:3<393:LIMEWI>2.0.ZU;2-U
Abstract
Objective: Sometimes the left internal mammary artery (LIMA) is not lo ng enough to reach a too lateral LAD when a left anterior small thorac otomy (LAST operation) is the surgical approach to graft the LAD. LIMA elongation with an inferior epigastric artery (IEA) can be an useful surgical option. Methods: From November 1994 to June 30, 1996, out of 289 patients who underwent LAST operation; 28 patients had a LIMA elon gation with an IEA, 20 patients had single vessel disease, 4 had two v essel disease, and 4 three vessel disease. Mean age was 62 +/- 22 (48- 84) and mean EF was 57 +/- 86. The IEA was used only when the LAD was totally or nearly occluded with no transmural myocardial infarction (h igh expected run off). Results: All patients had an uneventful recover y. After 315 +/- 104 days from surgery all were asymptomatic. A late d oppler flow assessment, performed in 28 patients, showed a high veloci ty diastolic how in 27. One patient was reoperated on because of graft occlusion 84 days after surgery. An angiography was performed after 8 7.5 +/- 23.3 days in 22 patients. All conduit and anastomoses were pat ent but one, (patency rate 21/22, 95.4%); another showed mild anastomo tical stenosis at the LIMA-IEA junction without clinical signs (perfec t patency rate 20/22, 90.9%). Conclusions: IEA elongation of LIMA is a n alternative strategy to reach a lateral LAD in selected cases; a sat isfying patency rate can be expected, when correct surgical indication s are used. (C) 1997 Elsevier Science B.V.